Literature DB >> 18587725

Hypertension, microalbuminuria and renal dysfunction: the Renal Dysfunction in Hypertension (REDHY) study.

Giovanni Cerasola1, Giuseppe Mulè, Santina Cottone, Emilio Nardi, Paola Cusimano.   

Abstract

AIMS: We assessed the prevalence of kidney dysfunction evaluated by different methods to estimate glomerular filtration rate (GFR) in a wide group of nondiabetic hypertensive patients, without cardiovascular (CV) complications and without known renal disease, participating in the Renal Dysfunction in Hypertension (REDHY) study.
METHODS: A total of 1,856 hypertensive individuals (mean age 47 +/- 14 years; men 53%), free from diabetes mellitus and CV complications, and consecutively attending our outpatient hypertension center, were enrolled. Patients with a body mass index >35 (calculated as kg/m(2)) were excluded. The GFR was estimated by the creatinine clearance rate (CrCl), the simplified Modification of Diet in Renal Disease Study prediction equation (MDRD), the Cockcroft-Gault formula (CG) and the Mayo Clinic quadratic equation (Mayo). A 24-hour urine sample was collected to evaluate CrCl and albumin excretion rate (AER). Albuminuria was defined as an AER greater than 20 microg/min.
RESULTS: The prevalence of albuminuria was 23.4% (22.7% microalbuminuria and 0.7% macroalbuminuria). Mild renal dysfunction (defined as 24-hour AER >20 microg/min in presence of eGFR > or =60 ml/min per 1.73 m(2)) was found in a proportion of patients ranging from 20.3% using CrCl, to 18.4% using the MDRD equation. The prevalence of overt renal insufficiency (estimated GFR <60 ml/min per 1.73 m(2)) was higher when CrCl (10.8%) or the MDRD equation (10%) was used to estimate the GFR, instead of the CG (7.4%) or Mayo equation (5.4%) (p<0.0001).
CONCLUSIONS: Mild renal dysfunction and overt renal insufficiency are highly prevalent among subjects with nonmalignant arterial hypertension without CV complications. However, the prevalence of moderate-to-severe renal function impairment is strongly influenced by the method used to estimate the GFR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18587725

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  5 in total

Review 1.  Metabolic syndrome in hypertensive patients: An unholy alliance.

Authors:  Giuseppe Mulè; Ilenia Calcaterra; Emilio Nardi; Giovanni Cerasola; Santina Cottone
Journal:  World J Cardiol       Date:  2014-09-26

2.  The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP).

Authors:  Amit P Amin; Adam T Whaley-Connell; Suying Li; Shu-Cheng Chen; Peter A McCullough; Mikhail N Kosiborod
Journal:  Am J Kidney Dis       Date:  2013-04       Impact factor: 8.860

3.  Clinical correlates of renal dysfunction in hypertensive patients without cardiovascular complications: the REDHY study.

Authors:  G Cerasola; G Mulè; E Nardi; P Cusimano; A Palermo; R Arsena; M Guarneri; C Geraci; S Cottone
Journal:  J Hum Hypertens       Date:  2010-01       Impact factor: 3.012

4.  Cystatin C, CRP, log TG/HDLc and metabolic syndrome are associated with microalbuminuria in hypertension.

Authors:  Rafaela do Socorro Souza e Silva Moura; Daniel França Vasconcelos; Eduardo Freitas; Flavio José Dutra de Moura; Tânia Torres Rosa; Joel Paulo Russomano Veiga
Journal:  Arq Bras Cardiol       Date:  2013-11-26       Impact factor: 2.000

5.  Urinary albumin excretion and prevalence of microalbuminuria in a general Chinese population: a cross-sectional study.

Authors:  Liuxia Yan; Jixiang Ma; Xiaolei Guo; Junli Tang; Jiyu Zhang; Zilong Lu; Huicheng Wang; Xiaoning Cai; Linhong Wang
Journal:  BMC Nephrol       Date:  2014-10-13       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.